Long-term Durability of Infliximab Treatment in Crohn's Disease and Efficacy of Dose “Escalation” in Patients Losing Response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term Durability of Infliximab Treatment in Crohn's Disease and Efficacy of Dose “Escalation” in Patients Losing Response

Published:2011-02 Issue:2 Volume:45 Page:113-118
ISSN:0192-0790
Container-title:Journal of Clinical Gastroenterology
language:en
Short-container-title:

Author:

Chaparro María,Panes Julián,García Valle,Mañosa Miriam,Esteve María,Merino Olga,Andreu Montserrat,Gutierrez Ana,Gomollón Fernando,Cabriada José Luis,Montoro Miguel Angel,Mendoza Juan Luis,Nos Pilar,Gisbert Javier P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CT-based body composition parameters predict the loss of response to infliximab in patients with Crohn's disease;The American Journal of the Medical Sciences;2024-09

2. Optimal Management of Refractory Crohn’s Disease: Current Landscape and Future Direction;Clinical and Experimental Gastroenterology;2024-03

3. Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: A literature review;World Journal of Gastroenterology;2023-08-07

4. Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn’s Disease (Versus-CD): Data from the ENEIDA Registry;Journal of Crohn's and Colitis;2023-07-31

5. Dose Escalation Patterns of Advanced Therapies in Crohn’s Disease and Ulcerative Colitis: A Systematic Literature Review;Advances in Therapy;2023-03-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP